Vascular Integrity, LLC

Vascular Integrity, LLC manufactures the VI ByPass Syringe®, an innovative blood and specimen collection device designed to streamline phlebotomy and line maintenance procedures. The company offers three product variants—Blue (for nurses with flush-lock line maintenance), Red (for phlebotomists in closed-system blood collection), and Clear (universal collection accommodating long- and short-neck bottles)—each incorporating proprietary VI Sliding Fluid Seal™ and VI Velocity Reduction Technology™ features. The ByPass Syringe is engineered to reduce hemolysis, minimize false positive blood cultures through blood diversion methodology, and help prevent CLABSI (central line-associated bloodstream infections) by avoiding breaks in aseptic technique during multi-step procedures. The device is evaluated and endorsed by ANTT (Aseptic Non-Touch Technique) for contamination reduction. Clinical evidence supporting the product includes hemolysis reduction studies and microbial contamination validation studies. The company positions its solution around healthcare cost reduction—each false positive blood culture costs $4,500–$9,000, with approximately 1.2 million US patients annually affected. Vascular Integrity is distributed by ICU Medical. The company is located in Huntington Beach, California.